Orgenesis Inc. Reports Board and Executive Compensation Changes
Ticker: ORGS · Form: 8-K · Filed: Jul 9, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0, $40,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
TL;DR
Orgenesis board shake-up and exec pay adjustments announced July 3rd.
AI Summary
Orgenesis Inc. announced on July 3, 2024, a change in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its key executives. The filing does not specify dollar amounts or exact names of departing/elected individuals.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- July 3, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 20271 Goldenrod Lane, Germantown, MD 20876 (address) — Principal executive offices
FAQ
What specific changes were made to Orgenesis Inc.'s board of directors?
The filing indicates the departure of certain directors and the election of new directors, but does not name the individuals involved.
Were there any changes to the executive officers of Orgenesis Inc.?
Yes, the filing reports the departure of certain officers.
What is the nature of the changes in compensatory arrangements?
The filing states there were changes to the compensatory arrangements of certain officers, but provides no specific details on the nature or value of these changes.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 3, 2024.
What is the principal executive office address for Orgenesis Inc.?
The principal executive office is located at 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 778 words · 3 min read · ~3 pages · Grade level 11.2 · Accepted 2024-07-09 16:05:35
Key Financial Figures
- $0 — ill have an exercise price per share of $0.65, the closing price of the Company's
- $40,000 — d to receive an annual cash retainer of $40,000 and an annual grant of a stock option t
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-24-026623.txt ( ) — 207KB
- orgs-20240703.xsd (EX-101.SCH) — 3KB
- orgs-20240703_lab.xml (EX-101.LAB) — 33KB
- orgs-20240703_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: July 9, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary